These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 14639137)
21. Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. Wang G; Xie G; Jiang T; Wang Y; Wang W; Ji H; Liu M; Chen L; Li L Anesth Analg; 2012 Aug; 115(2):239-43. PubMed ID: 21737704 [TBL] [Abstract][Full Text] [Related]
22. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Mongan PD; Hosking MP Anesthesiology; 1992 Jul; 77(1):38-46. PubMed ID: 1610009 [TBL] [Abstract][Full Text] [Related]
23. Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. Martin K; Gertler R; MacGuill M; Mayr NP; Hapfelmeier A; Hörer J; Vogt M; Tassani P; Wiesner G Br J Anaesth; 2013 Apr; 110(4):615-21. PubMed ID: 23213034 [TBL] [Abstract][Full Text] [Related]
24. Tranexamic acid and primary coronary artery bypass surgery: a prospective study. Maddali MM; Rajakumar MC Asian Cardiovasc Thorac Ann; 2007 Aug; 15(4):313-9. PubMed ID: 17664205 [TBL] [Abstract][Full Text] [Related]
25. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. Andreasen JJ; Nielsen C Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. Chauhan S; Kumar BA; Rao BH; Rao MS; Dubey B; Saxena N; Venugopal P Ann Thorac Surg; 2000 Oct; 70(4):1308-12. PubMed ID: 11081890 [TBL] [Abstract][Full Text] [Related]
30. Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost. Ray MJ; O'Brien MF Ann Thorac Surg; 2001 Mar; 71(3):838-43. PubMed ID: 11269462 [TBL] [Abstract][Full Text] [Related]
31. Peri-operative blood-loss after total hip arthroplasty can be significantly reduced with topical application of epsilon-aminocaproic acid. Sucher MG; Giordani M; Figoni A; Nedopil AJ Int Orthop; 2016 Oct; 40(10):2019-2023. PubMed ID: 26744168 [TBL] [Abstract][Full Text] [Related]
33. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. Alvarez JM; Jackson LR; Chatwin C; Smolich JJ J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294 [TBL] [Abstract][Full Text] [Related]
34. Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study. Tobe CE; Vocelka C; Sepulvada R; Gillis B; Nessly M; Verrier ED; Hofer BO J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1007-13; discussion 1013-4. PubMed ID: 8501929 [TBL] [Abstract][Full Text] [Related]
35. Epsilon-aminocaproic acid influence in postoperative [corrected] bleeding and hemotransfusion [corrected] in mitral valve surgery. Benfatti RÁ; Carli AF; Silva GV; Dias AE; Goldiano JA; Pontes JC Rev Bras Cir Cardiovasc; 2010; 25(4):510-5. PubMed ID: 21340381 [TBL] [Abstract][Full Text] [Related]
36. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. Casati V; Della Valle P; Benussi S; Franco A; Gerli C; Baili P; Alfieri O; D'Angelo A J Thorac Cardiovasc Surg; 2004 Jul; 128(1):83-91. PubMed ID: 15224025 [TBL] [Abstract][Full Text] [Related]
37. Gender does not influence epsilon-aminocaproic acid concentrations in adults undergoing cardiopulmonary bypass. Butterworth J; James RL; Lin YA; Bennett J; Prielipp RC Anesth Analg; 2001 Jun; 92(6):1384-90. PubMed ID: 11375809 [TBL] [Abstract][Full Text] [Related]
38. Implementation of an institutional protocol for rational use of blood products and its impact on postoperative of coronary artery bypass graft surgery. Silva PG; Ikeoka DT; Fernandes VA; Lasta NS; Silva DP; Okada MY; Izidoro BA; Garcia JC; Baruzzi AC; Furlan V Einstein (Sao Paulo); 2013; 11(3):310-6. PubMed ID: 24136757 [TBL] [Abstract][Full Text] [Related]
39. Topically Applied Epsilon-Aminocaproic Acid Reduces Blood Loss and Length of Hospital Stay After Total Knee Arthroplasty. Harper RA; Sucher MG; Giordani M; Nedopil AJ Orthopedics; 2017 Nov; 40(6):e1044-e1049. PubMed ID: 28968480 [TBL] [Abstract][Full Text] [Related]
40. Blood loss and transfusion requirements with epsilon-aminocaproic acid use during cranial vault reconstruction surgery. Thompson ME; Saadeh C; Watkins P; Nagy L; Demke J J Clin Anesth; 2017 Feb; 36():153-157. PubMed ID: 28183556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]